Lutris Pharma
Entry
2025
Hold
1yr
Status
Active
Who owns Lutris Pharma?
Lutris Pharma is currently owned by Columbus Venture Partners through Columbus Life Sciences Fund III (2021 vintage), since 2025.
Hand-verified · updated 2026-08-09
More from Columbus Life Sciences Fund III
Other portfolio companies in the same fund.
United States
SpainMore Columbus Venture Partners portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack Lutris Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Lutris Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue